Humana Inc. (HUM)
Humana was organised as a Delaware corporation in 1964 and is run from Louisville, Kentucky. It sells health insurance and, through CenterWell, delivers health care itself. At the end of 2025 it had about 15 million members in its medical benefit plans and about 4.7 million in specialty products.
Compare with another name What $10,000 in Humana became Open in your desk ↗
Latest results
this quarterthe same quarter a year earlierHover a bar for its figure.
this yearthe year beforeHover a bar for its figure.
The years before, in words
Humana (HUM) reported revenue of $129.7 billion for fiscal 2025, the year ended 31 December 2025, up 10.1% on the year before. Net income was $1.2 billion and diluted earnings per share $9.84. Revenue was $117.8 billion in fiscal 2024, $106.4 billion in fiscal 2023, $92.9 billion in fiscal 2022 and $83.1 billion in fiscal 2021. Net income in the same years was $1.2 billion, $2.5 billion, $2.8 billion and $2.9 billion. Over the twelve months to 30 September 2026, Humana reported revenue of $154.2 billion and net income of $1.2 billion. Revenue grew 10.9% a year, compounded, over the five years to fiscal 2025. Humana declared $3.54 a share in dividends over the last four quarters and had 120 million shares outstanding at the latest filed count. At the close of 6 November 2026 the market cap of Humana was $52.1 billion, 42.2 times its earnings over the last twelve months.Ratios
From the filings
ROE6.6%
ROCE7.6%
Operating margin1.5%
Net margin0.8%
FCF margin2.0%
Interest cover3.2x
Debt to equity0.66x
Cash conversion2.99x
Share count, last 12 months-0.1%
Sales CAGR, 3 years11.8%
Profit CAGR, 3 years-24.9%
EPS, TTM$10.28
At the close of 6 November 2026
Price$433.51
Market cap$52.1 billion
Stock P/E42.2x
Price to book2.8x
EV / EBITDA19.1x
Dividend yield0.8%
Market cap / sales0.34x
52-week high$433.51
52-week low$163.67
Price, 1 year72.6%
Price CAGR, 3 years-4.5%
Price CAGR, 5 years-0.9%
29 ready-made ratios, from FCF yield to net debt to EBITDA, wait on the Formulas page, each with what it tells you. Browse and add them →
Worked from the filed figures; hover a name for the formula.
Read more
The priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on the borrowing lines of Humana Inc.'s balance sheet, added together, finance leases inside them only where the company puts them there; operating leases are a separate line. Nothing here is a valuation or a view.HUMgreeksoup.ai
Daily prices to 6 November 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.
Read more
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Before the quarters on file begin, P/E, price to book and market cap to sales stand on each annual report from the day it was filed. Drawn in your browser; the range and overlay you pick are remembered here only.Quarterly results
| Q4 FY2021 * | Q1 FY2022 | Q2 FY2022 | Q3 FY2022 | Q4 FY2022 * | Q1 FY2023 | Q2 FY2023 | Q3 FY2023 | Q4 FY2023 * | Q1 FY2024 | Q2 FY2024 | Q3 FY2024 | Q4 FY2024 * | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 * | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21,054 | 23,970 | 23,662 | 22,799 | 22,439 | 26,742 | 26,747 | 26,423 | 26,462 | 29,611 | 29,540 | 29,397 | 29,213 | 32,112 | 32,388 | 32,649 | 32,515 | 39,648 | 40,867 | 41,155 |
| SG&A | 3,395 | 2,886 | 3,173 | 3,061 | 3,551 | 2,979 | 3,111 | 3,271 | 3,827 | 3,042 | 3,148 | 3,339 | 4,167 | 3,380 | 3,547 | 4,085 | 4,438 | 4,024 | 3,978 | 4,598 |
| Operating income | 61.0 | 1,289 | 1,215 | 1,172 | 124 | 1,719 | 1,436 | 1,206 | -348 | 1,236 | 1,141 | 728 | -543 | 2,014 | 1,098 | 400 | -808 | 1,754 | 1,360 | 75.0 |
| Operating margin | 0% | 5% | 5% | 5% | 1% | 6% | 5% | 5% | -1% | 4% | 4% | 2% | -2% | 6% | 3% | 1% | -2% | 4% | 3% | 0% |
| Interest expense | 91.0 | 90.0 | 101 | 102 | 108 | 113 | 120 | 114 | 146 | 159 | 168 | 169 | 164 | 160 | 157 | 168 | 146 | 193 | 197 | 217 |
| Pre-tax income | -64.0 | 1,216 | 1,124 | 1,300 | -76.0 | 1,597 | 1,252 | 1,086 | -615 | 990 | 901 | 635 | -906 | 1,691 | 741 | 134 | -1,011 | 1,595 | 952 | 216 |
| Tax rate | n/a | 24% | 38% | 8% | n/a | 22% | 24% | 24% | n/a | 25% | 25% | 24% | n/a | 24% | 24% | -64% | n/a | 25% | 25% | 19% |
| Net income | -14.0 | 930 | 696 | 1,195 | -15.0 | 1,239 | 959 | 832 | -541 | 741 | 679 | 480 | -693 | 1,244 | 545 | 195 | -796 | 1,186 | 694 | 162 |
| Net margin | -0% | 4% | 3% | 5% | -0% | 5% | 4% | 3% | -2% | 3% | 2% | 2% | -2% | 4% | 2% | 1% | -2% | 3% | 2% | 0% |
| Diluted EPS | -$0.11 | $7.29 | $5.48 | $9.39 | -$0.12 | $9.87 | $7.66 | $6.71 | -$4.42 | $6.11 | $5.62 | $3.98 | -$5.76 | $10.30 | $4.51 | $1.62 | -$6.61 | $9.83 | $5.73 | $1.33 |
| Operating cash flow | -96.0 | 302 | 959 | 8,453 | -5,127 | 6,687 | 3,176 | 1,252 | -7,134 | 423 | 1,213 | 1,858 | -528 | 331 | 1,271 | 971 | -1,652 | 1,254 | 1,966 | 2,163 |
| Capital expenditure | 371 | 295 | 279 | 288 | 258 | 223 | 264 | 234 | 283 | 177 | 114 | 130 | 154 | 95.0 | 114 | 135 | 202 | 121 | 132 | 137 |
| Free cash flow | -467 | 7.0 | 680 | 8,165 | -5,385 | 6,464 | 2,912 | 1,018 | -7,417 | 246 | 1,099 | 1,728 | -682 | 236 | 1,157 | 836 | -1,854 | 1,133 | 1,834 | 2,026 |
| Buybacks | 43.0 | 1,024 | 4.0 | 4.0 | 1,064 | 94.0 | 529 | 379 | 571 | 717 | 49.0 | 2.0 | 49.0 | 9.0 | 100 | 0.0 | 42.0 | 107 | 1.0 | 2.0 |
| Dividends paid | 91.0 | 91.0 | 100 | 100 | 101 | 100 | 111 | 109 | 111 | 109 | 107 | 107 | 108 | 108 | 106 | 107 | 109 | 107 | 107 | 106 |
| Shares outstanding | 127m | 126m | 127m | 127m | 125m | 125m | 124m | 123m | 121m | 121m | 120m | 120m | 121m | 121m | 120m | 120m | 121m | 120m | 120m | 120m |
| Filing | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
Each quarter as filed, linked to its filing.
Read more
* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.Income statement (profit and loss)
Play it forward: change any box and its column follows; every box opens at the company's own record, shown under the row's name, and says when you set it outside every year in the table.
Read more
Each column runs from the last twelve months as filed to the year chosen in its heading, at a yearly rate. Sales growth starts at the company's own five-year rate and eases a third of the way each year toward the median of the 98 peers in Insurance (8.5% a year), because a rate far from the rest rarely lasts. Before you open a year, the strip reads today's price backwards: the yearly sales growth that brings EPS, at the company's own margins, tax and share count, to today's price at the median P/E of the 97 peers in Insurance (12.0). Low, middle, high opens three columns for one year: the low and high cases take the company's own weaker and stronger years in the table (the lower and upper quarter of its yearly sales growth and operating margin) and the lower and higher of today's P/E and its peers'; the middle is the boxes as they open. Net income keeps the share that went to minority holders; EPS is net income over the diluted shares, on the same basis as the EPS in the table. The price is that year's EPS at the P/E you set, and the yearly return runs from today's price to the year's end. These are your assumptions and your arithmetic, not an estimate of ours. The link carries your columns, so you can send the forecast to someone.| FY2007 | FY2008 † | FY2009 † | FY2010 † | FY2011 | FY2012 | FY2013 † | FY2014 † | FY2015 † | FY2016 † | FY2017 † | FY2018 | FY2019 | FY2020 | FY2021 † | FY2022 † | FY2023 | FY2024 | FY2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25,290 | 28,753 | 30,743 | 33,596 | 36,832 | 39,126 | 41,313 | 48,500 | 54,289 | 54,379 | 53,767 | 56,912 | 64,888 | 77,155 | 83,064 | 92,870 | 106,374 | 117,761 | 129,664 | 154,185 |
| Selling, general and administrative | 3,476 | 3,740 | 4,014 | 4,380 | 5,395 | 5,830 | 6,355 | 7,639 | 7,295 | 7,173 | 6,567 | 7,525 | 7,381 | 10,052 | 10,121 | 12,671 | 13,188 | 13,696 | 15,450 | 17,038 |
| Operating income | 1,358 | 1,073 | 1,708 | 1,855 | 2,344 | 2,016 | 2,061 | 2,362 | 2,347 | 1,741 | 4,262 | 3,100 | 3,192 | 4,986 | 3,148 | 3,800 | 4,013 | 2,562 | 2,704 | 2,381 |
| Operating margin | 5.4% | 3.7% | 5.6% | 5.5% | 6.4% | 5.2% | 5.0% | 4.9% | 4.3% | 3.2% | 7.9% | 5.4% | 4.9% | 6.5% | 3.8% | 4.1% | 3.8% | 2.2% | 2.1% | 1.5% |
| Interest expense | 68.9 | 80.3 | 106 | 105 | 109 | 105 | 140 | 192 | 186 | 189 | 242 | 218 | 242 | 283 | 326 | 401 | 493 | 660 | 631 | 753 |
| Pre-tax income | 1,289 | 993 | 1,602 | 1,750 | 2,235 | 1,911 | 1,921 | 2,170 | 2,431 | 1,552 | 4,020 | 2,074 | 3,470 | 4,674 | 3,419 | 3,564 | 3,320 | 1,620 | 1,438 | 1,752 |
| Income tax | 456 | 346 | 562 | 650 | 816 | 689 | 690 | 1,023 | 1,155 | 938 | 1,572 | 391 | 763 | 1,307 | 485 | 762 | 836 | 413 | 250 | 424 |
| Effective tax rate | 35.3% | 34.8% | 35.1% | 37.2% | 36.5% | 36.1% | 35.9% | 47.1% | 47.5% | 60.4% | 39.1% | 18.9% | 22.0% | 28.0% | 14.2% | 21.4% | 25.2% | 25.5% | 17.4% | 24.2% |
| Net income | 834 | 647 | 1,040 | 1,099 | 1,419 | 1,222 | 1,231 | 1,147 | 1,276 | 614 | 2,448 | 1,683 | 2,707 | 3,367 | 2,933 | 2,806 | 2,489 | 1,207 | 1,188 | 1,246 |
| Net margin | 3.3% | 2.3% | 3.4% | 3.3% | 3.9% | 3.1% | 3.0% | 2.4% | 2.4% | 1.1% | 4.6% | 3.0% | 4.2% | 4.4% | 3.5% | 3.0% | 2.3% | 1.0% | 0.9% | 0.8% |
| Diluted EPS | $4.91 | $3.83 | $6.15 | $6.47 | $8.46 | $7.47 | $7.73 | $7.36 | $8.44 | $4.07 | $16.81 | $12.16 | $20.10 | $25.31 | $22.67 | $22.08 | $20.00 | $9.98 | $9.84 | $10.28 |
| Filing | 10-K | 8-K | 8-K | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
From each year's 10-K, linked; TTM is the last four quarters.
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.Cash flow
Follow the cash: free cash flow, which is operating cash flow less capital expenditure and share-based pay, for five years and after, in today's money.
Read more
The figure a share at the top is what a discounted cash flow calls intrinsic value, worked out on your assumptions. Everything after year five is one sum: the sixth year's cash, growing at the long-run rate every year after, added up and brought back to today's money. Each year runs from the last twelve months as filed. Sales growth opens where Play it forward does: the company's own five-year rate, easing a third of the way each year toward the median of the 98 peers in Insurance (8.5% a year); change a year and the years after it follow. Operating cash flow, capital expenditure and share-based pay open at the company's own median share of sales over its last five years, shown under each row. Share-based pay is taken off because operating cash flow adds back the shares paid to staff as if they cost nothing; set it to 0 to leave it in. Capital spending counts every capital line the company files in its cash flow, such as equipment it leases to customers, software, wells or property it develops, named under the row, while the Capital expenditure row in the table below stays the one line as filed; buying a business, securities or a finished property is not counted. The discount rate opens at 10%, about what US stocks have returned a year over the long run, so it is the return you give up by holding this company instead of the market; the growth after year five opens at 3%, a little under the US economy's long-run growth in dollars, because no company outgrows it for ever. Net debt is the debt and short-term borrowings less the cash on the latest balance sheet that shows the debt; the figure per share divides what is left by the diluted share count. These are your assumptions and your arithmetic, not an estimate of ours. The link carries them, so you can send them to someone.| FY2007 | FY2008 † | FY2009 † | FY2010 † | FY2011 | FY2012 | FY2013 † | FY2014 † | FY2015 † | FY2016 † | FY2017 † | FY2018 | FY2019 | FY2020 | FY2021 † | FY2022 † | FY2023 | FY2024 | FY2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,224 | 982 | 1,422 | 2,242 | 2,079 | 1,923 | 1,716 | 1,618 | 868 | 1,936 | 4,051 | 2,173 | 5,284 | 5,639 | 2,262 | 4,587 | 3,981 | 2,966 | 921 | 3,731 |
| Capital expenditure | 239 | 262 | 185 | 222 | 346 | 410 | 441 | 528 | 523 | 527 | 524 | 612 | 736 | 964 | 1,342 | 1,137 | 1,004 | 575 | 546 | 592 |
| Free cash flow | 985 | 721 | 1,237 | 2,019 | 1,733 | 1,513 | 1,275 | 1,090 | 345 | 1,409 | 3,527 | 1,561 | 4,548 | 4,675 | 920 | 3,450 | 2,977 | 2,391 | 375 | 3,139 |
| Free cash flow margin | 3.9% | 2.5% | 4.0% | 6.0% | 4.7% | 3.9% | 3.1% | 2.2% | 0.6% | 2.6% | 6.6% | 2.7% | 7.0% | 6.1% | 1.1% | 3.7% | 2.8% | 2.0% | 0.3% | 2.0% |
| Cash from investing | -1,845 | -498 | -1,859 | -1,811 | -1,358 | -1,965 | -1,182 | -63.0 | 320 | -1,362 | -2,941 | -3,087 | -1,278 | -3,065 | -6,556 | -1,006 | -3,492 | -2,952 | 2,273 | -4,263 |
| Cash from financing | 921 | -554 | 80.0 | -371 | -1,017 | -29.0 | -702 | -758 | -552 | 732 | -945 | -785 | -2,295 | -1,955 | 3,015 | -1,914 | -856 | -2,487 | -1,215 | 2,079 |
| Depreciation and amortisation | 185 | 220 | 250 | 263 | 303 | 338 | 309 | 328 | 354 | 388 | 410 | 444 | 575 | 616 | 596 | 709 | 779 | 839 | 698 | 644 |
| Share-based compensation | 42.1 | 55.4 | 65.9 | 62.9 | 67.0 | 82.0 | 92.0 | 98.0 | 109 | 115 | 157 | 137 | 163 | 181 | 180 | 216 | 175 | 207 | 241 | 231 |
| Buybacks | 27.4 | 106 | 23.0 | 108 | 541 | 518 | 531 | 872 | 385 | 104 | 3,365 | 1,090 | 1,070 | 1,820 | 79.0 | 2,096 | 1,573 | 817 | 151 | 152 |
| Dividends paid | n/a | n/a | 0.0 | 0.0 | 82.0 | 165 | 168 | 172 | 172 | 177 | 220 | 265 | 291 | 323 | 90.0 | 98.0 | 431 | 431 | 430 | 429 |
| Dividend per share | n/a | n/a | n/a | $0.00 | $0.75 | $1.03 | $1.07 | $1.11 | $1.15 | $1.16 | $1.49 | $1.90 | $2.15 | $2.43 | $2.73 | $3.06 | $3.44 | $3.54 | $3.54 | $3.54 |
| Diluted shares, weighted | n/a | 169m | 169m | 170m | 168m | 163m | 159m | 156m | 151m | 151m | 146m | 138m | 135m | 133m | 129m | 127m | 124m | 121m | 121m | 122m |
| Shares outstanding at period end | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 120m |
| Filing | 10-K | 8-K | 8-K | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Cash paid in the year, from the cash flow statement.
Read more
The dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.Balance sheet
| FY2007 | FY2008 † | FY2009 † | FY2010 † | FY2011 | FY2012 | FY2013 † | FY2014 † | FY2015 † | FY2016 † | FY2017 † | FY2018 | FY2019 | FY2020 | FY2021 † | FY2022 † | FY2023 | FY2024 | FY2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Funded by | ||||||||||||||||||||
| Shareholders' equity | 4,029 | 4,457 | 5,776 | 6,924 | 8,063 | 8,847 | 9,316 | 9,646 | 10,346 | 10,685 | 9,842 | 10,161 | 12,037 | 13,728 | 16,080 | 15,311 | 16,262 | 16,375 | 17,657 | 18,825 |
| Non-controlling interest | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.0 | 23.0 | 59.0 | 56.0 | 70.0 | 80.0 | 63.0 |
| Debt | n/a | 1,937 | 1,678 | 2,078 | 1,965 | 2,935 | 3,003 | 4,159 | 4,394 | 4,304 | 5,061 | 6,069 | 5,666 | 6,660 | 12,494 | 11,126 | 11,656 | 11,721 | 12,369 | 12,504 |
| Operating lease liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 332 | 355 | 546 | 456 | 444 | 392 | 418 | n/a |
| Other liabilities | n/a | 6,648 | 6,699 | 7,101 | 7,680 | 8,197 | 8,416 | 9,722 | 9,965 | 10,407 | 12,275 | 9,183 | 11,039 | 14,226 | 15,215 | 16,103 | 18,647 | 17,921 | 18,385 | 25,893 |
| Total liabilities and equity | n/a | 13,042 | 14,153 | 16,103 | 17,708 | 19,979 | 20,735 | 23,527 | 24,705 | 25,396 | 27,178 | 25,413 | 29,074 | 34,969 | 44,358 | 43,055 | 47,065 | 46,479 | 48,909 | 57,285 |
| Owned | ||||||||||||||||||||
| Fixed assets | n/a | 711 | 679 | 815 | 912 | 1,098 | 1,218 | 1,228 | 1,384 | 1,505 | 1,584 | 1,735 | 1,955 | 2,371 | 3,073 | 3,221 | 3,030 | 2,532 | 2,231 | 2,070 |
| Goodwill | n/a | 1,963 | 1,993 | 2,568 | 2,740 | 3,640 | 3,253 | 3,231 | 3,265 | 3,272 | 3,281 | 3,897 | 3,928 | 4,447 | 11,092 | 9,142 | 9,550 | 9,631 | 9,686 | 10,547 |
| Intangible assets | n/a | n/a | n/a | 399 | 435 | 731 | 693 | 440 | 357 | 280 | 226 | 245 | 177 | 329 | 2,639 | 1,765 | 1,693 | 1,443 | 1,128 | 1,184 |
| Investments | n/a | 5,215 | 7,497 | 8,372 | 9,453 | 9,847 | 9,800 | 9,547 | 9,110 | 9,798 | 12,302 | 10,437 | 11,378 | 13,766 | 13,972 | 14,261 | 17,008 | 18,635 | 16,196 | 18,780 |
| Cash and equivalents | 2,040 | 1,970 | 1,614 | 1,673 | 1,377 | 1,306 | 1,138 | 1,935 | 2,571 | 3,877 | 4,042 | 2,343 | 4,054 | 4,673 | 3,394 | 5,061 | 4,694 | 2,221 | 4,200 | 6,935 |
| Receivables | n/a | n/a | 824 | 959 | 1,034 | 733 | 950 | 1,053 | 1,161 | 1,280 | 854 | 1,015 | 1,056 | 1,138 | 1,814 | 1,674 | 2,035 | 2,704 | 3,270 | 2,865 |
| Other assets | n/a | 3,181 | 1,547 | 1,316 | 1,757 | 2,624 | 3,683 | 6,093 | 6,857 | 5,384 | 4,889 | 5,741 | 6,526 | 8,245 | 8,374 | 7,931 | 9,055 | 9,313 | 12,198 | 14,904 |
| Total assets | n/a | 13,042 | 14,153 | 16,103 | 17,708 | 19,979 | 20,735 | 23,527 | 24,705 | 25,396 | 27,178 | 25,413 | 29,074 | 34,969 | 44,358 | 43,055 | 47,065 | 46,479 | 48,909 | 57,285 |
| Filing | 10-K | 8-K | 8-K | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
At the fiscal year end; the TTM column is the latest quarter end.
Read more
Both totals are the company's own. Other liabilities is the filed total less the rows above it: payables, deferred revenue, taxes, borrowings the rows above do not carry and the rest; other assets is the same on the other side. Investments add the current and non-current lines as filed. Debt is the company's own stated total where it files one, otherwise its long-term debt with the current maturities, never parts added together. A row is left blank in a year where the lines shown overlap and the remainder would fall below nil.Compounded growth
| 10 years | 5 years | 3 years | TTM | |
|---|---|---|---|---|
| Sales growth, compounded | 9.1% | 10.9% | 11.8% | 22.0% |
| Profit growth, compounded | -0.7% | -18.8% | -24.9% | -3.5% |
| Return on equity, average | 16.0% | 13.2% | 9.8% | 6.7% |
Yearly growth, compounded; TTM is the last four quarters against the four before.
Read more
Return on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.Questions
What was Humana's revenue in fiscal 2025?
Humana (HUM) reported revenue of $129.7 billion for fiscal 2025, the year ended 31 December 2025, up 10.1% on the year before.
How much did Humana earn in fiscal 2025?
Net income was $1.2 billion for fiscal 2025, and diluted earnings per share $9.84.
What is Humana's P/E ratio?
At the close of 6 November 2026, Humana traded at 42.2 times its earnings over the twelve months to 30 September 2026.
What is Humana's market cap?
The market cap of Humana was $52.1 billion at the close of 6 November 2026.
Does Humana pay a dividend?
Yes. Humana declared $3.54 a share in dividends over the four quarters to 30 September 2026.
Peers: Insurance
| Company | Market cap | P/E | ROE | Op. margin | Sales growth TTM | Debt to equity | Div. yield |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. UNH | $353.2 billion | 22.51 | 15.3% | 5.3% | 3.3% | 0.71 | 2.3% |
| Elevance Health, Inc. ELV | $92.0 billion | 18.15 | 11.5% | 2.7% | 3.6% | 0.69 | 1.6% |
| Cigna Group CI | $77.4 billion | 12.96 | 13.8% | 3.4% | 6.8% | 0.72 | 2.1% |
| Metlife Inc. MET | $62.0 billion | 12.80 | 23.1% | 8.2% | 14.8% | 0.64 | 2.4% |
| Aflac Inc. AFL | $61.5 billion | 18.24 | 12.0% | 25.9% | -6.2% | 0.28 | 1.9% |
| Humana Inc. HUM | $52.1 billion | 42.17 | 6.6% | 1.5% | 22.0% | 0.66 | 0.8% |
| Centene Corp. CNC | $34.5 billion | 23.88 | 6.6% | 0.5% | 9.7% | 0.70 | n/a |
| Molina Healthcare, Inc. MOH | $10.8 billion | n/a | -1.2% | 0.4% | -0.9% | 0.91 | n/a |
| Oscar Health, Inc. OSCR | $9.5 billion | 12.66 | 38.5% | 5.4% | 54.8% | 0.19 | n/a |
| Clover Health Investments, Corp. CLOV | $2.6 billion | 483.00 | 3.2% | 0.5% | 54.5% | 0.00 | n/a |
| Trupanion, Inc. TRUP | $1.6 billion | 60.31 | 6.7% | 1.8% | 11.4% | 0.26 | n/a |
| Alignment Healthcare, Inc. ALHC | $1.5 billion | 56.38 | 10.4% | 0.9% | 35.9% | 1.17 | n/a |
All 112 in Insurance
| Company | Market cap | P/E | ROE | Op. margin | Sales growth TTM | Debt to equity | Div. yield |
|---|---|---|---|---|---|---|---|
| Berkshire Hathaway Inc. BRK.B | $1.23 trillion | 14.36 | 11.5% | 15.0% | 3.9% | n/a | n/a |
| UnitedHealth Group Inc. UNH | $353.2 billion | 22.51 | 15.3% | 5.3% | 3.3% | 0.71 | 2.3% |
| Chubb Ltd. CB | $139.6 billion | 12.77 | 15.3% | 22.3% | 5.7% | 0.25 | 1.1% |
| Progressive Corp. PGR | $132.0 billion | 11.48 | 33.7% | 16.0% | 7.7% | 0.24 | 6.1% |
| Marsh & McLennan Companies, Inc. MRSH | $97.3 billion | 24.49 | 27.1% | 21.4% | 7.6% | 1.27 | 1.8% |
| Elevance Health, Inc. ELV | $92.0 billion | 18.15 | 11.5% | 2.7% | 3.6% | 0.69 | 1.6% |
| Travelers Companies, Inc. TRV | $81.0 billion | 10.31 | 28.7% | 21.2% | 1.1% | 0.34 | 1.2% |
| Cigna Group CI | $77.4 billion | 12.96 | 13.8% | 3.4% | 6.8% | 0.72 | 2.1% |
| Manulife Financial Corporation MFC * | $72.5 billion | 19.66 | 11.1% | n/a | n/a | 0.15 | 3.3% |
| Arthur J. Gallagher & Co. AJG | $72.2 billion | 43.06 | 7.1% | 13.1% | 25.6% | 0.54 | 1.0% |
| Aon plc AON | $71.0 billion | 18.34 | 38.9% | 26.3% | 3.8% | 2.61 | 0.9% |
| Allstate Corp. ALL | $63.4 billion | 5.77 | 35.9% | 21.1% | 5.1% | 0.23 | 1.7% |
| Metlife Inc. MET | $62.0 billion | 12.80 | 23.1% | 8.2% | 14.8% | 0.64 | 2.4% |
| Aflac Inc. AFL | $61.5 billion | 18.24 | 12.0% | 25.9% | -6.2% | 0.28 | 1.9% |
| Humana Inc. HUM | $52.1 billion | 42.17 | 6.6% | 1.5% | 22.0% | 0.66 | 0.8% |
| Prudential Financial Inc. PRU | $40.9 billion | 10.86 | 13.1% | 7.8% | 6.5% | 0.67 | 4.7% |
| American International Group, Inc. AIG | $40.3 billion | 12.66 | 8.5% | 14.5% | 1.2% | 0.22 | 2.4% |
| Sun Life Financial Inc. SLF * | $39.6 billion | 16.24 | 14.5% | n/a | 8.0% | 0.33 | 3.7% |
| Hartford Insurance Group, Inc. HIG | $35.8 billion | 8.11 | 24.4% | 18.2% | 6.2% | 0.23 | 1.8% |
| Arch Capital Group Ltd. ACGL | $34.9 billion | 8.78 | 19.0% | 25.9% | -3.9% | 0.19 | 4.7% |
| Centene Corp. CNC | $34.5 billion | 23.88 | 6.6% | 0.5% | 9.7% | 0.70 | n/a |
| Everest Group, Ltd. EG | $30.6 billion | 8.69 | 13.3% | 13.9% | -8.7% | n/a | 1.9% |
| Willis Towers Watson plc WTW | $30.3 billion | 20.07 | 20.1% | 22.0% | 4.8% | 0.84 | 1.2% |
| Cincinnati Financial Corp. CINF | $28.5 billion | 10.88 | 16.5% | 24.8% | 9.9% | 0.05 | 2.0% |
| W. R. Berkley Corp. WRB | $27.9 billion | 15.91 | 19.4% | n/a | 1.5% | n/a | 2.5% |
| Markel Group Inc. MKL | $23.7 billion | 13.77 | 9.7% | 15.7% | 2.5% | 0.24 | n/a |
| Principal Financial Group Inc. PFG | $23.6 billion | 12.35 | 16.7% | 14.7% | 5.2% | 0.37 | 2.9% |
| Brown & Brown, Inc. BRO | $23.6 billion | 22.82 | 9.7% | n/a | 26.1% | 0.62 | 0.9% |
| Loews Corp. L | $22.2 billion | 15.20 | 8.1% | 10.8% | 2.8% | 0.46 | 0.2% |
| Reinsurance Group of America Inc. RGA | $17.0 billion | 10.12 | 14.7% | 8.0% | 22.5% | 0.46 | 1.4% |
| Assurant, Inc. AIZ | $15.1 billion | 14.45 | 17.9% | 9.8% | 9.4% | n/a | 1.1% |
| Corebridge Financial, Inc. CRBG | $15.0 billion | 7.31 | 32.7% | 16.6% | 13.3% | 0.83 | 2.9% |
| Globe Life Inc. GL | $14.5 billion | 10.53 | 17.9% | 23.3% | 5.6% | 0.45 | 0.8% |
| Renaissancere Holdings Ltd. RNR | $14.2 billion | 9.78 | 13.8% | 30.1% | -20.9% | 0.21 | 0.5% |
| Equitable Holdings, Inc. EQH | $14.1 billion | 10.11 | n/a | 16.3% | 8.6% | n/a | 2.2% |
| CNA Financial Corp. CNA | $12.8 billion | 12.47 | 10.1% | 8.5% | 2.1% | 0.24 | 8.2% |
| American Financial Group Inc. AFG | $12.8 billion | 12.61 | 21.6% | 15.2% | 3.3% | 0.39 | 4.5% |
| Erie Indemnity Co. ERIE | $12.6 billion | 24.78 | 22.6% | 17.9% | 2.0% | n/a | 2.1% |
| Unum Group UNM | $11.9 billion | 54.43 | 2.3% | 2.4% | -4.2% | 0.35 | 2.5% |
| Fidelity National Financial, Inc. FNF | $11.7 billion | 11.21 | 14.2% | 17.0% | 6.4% | 0.59 | 4.7% |
| Molina Healthcare, Inc. MOH | $10.8 billion | n/a | -1.2% | 0.4% | -0.9% | 0.91 | n/a |
| Oscar Health, Inc. OSCR | $9.5 billion | 12.66 | 38.5% | 5.4% | 54.8% | 0.19 | n/a |
| Old Republic International Corp. ORI | $9.5 billion | 8.92 | 18.8% | 13.8% | 12.5% | n/a | 9.2% |
| Voya Financial, Inc. VOYA | $8.9 billion | 15.92 | 16.4% | 8.9% | -0.3% | 0.55 | 1.9% |
| Primerica, Inc. PRI | $8.9 billion | 11.48 | 28.2% | 29.4% | 8.3% | 0.21 | 1.6% |
| Jackson Financial Inc. JXN | $8.7 billion | 10.73 | 10.4% | 56.7% | 34.1% | 0.33 | 2.7% |
| Kinsale Capital Group, Inc. KNSL | $8.6 billion | 16.72 | 27.4% | 33.7% | 8.3% | 0.12 | 0.2% |
| Hanover Insurance Group, Inc. THG | $8.3 billion | 11.61 | 21.8% | 15.2% | 5.0% | 0.25 | n/a |
| Axis Capital Holdings Ltd. AXS | $7.6 billion | 8.06 | 16.1% | 17.5% | 9.8% | 0.21 | 1.7% |
| Lincoln National Corp. LNC | $7.6 billion | 2.48 | 35.2% | 20.0% | 10.3% | 0.68 | 4.5% |
| First American Financial Corp. FAF | $6.8 billion | 9.44 | 13.6% | 11.9% | 14.1% | n/a | 3.3% |
| Enact Holdings, Inc. ACT | $6.3 billion | 9.67 | 13.1% | 68.5% | 2.5% | 0.14 | 1.9% |
| RLI Corp. RLI | $6.3 billion | 15.93 | 23.3% | 25.8% | 4.6% | 0.18 | 3.9% |
| Hagerty, Inc. HGTY | $6.2 billion | n/a | 23.4% | 4.5% | -0.9% | 0.96 | n/a |
| Selective Insurance Group Inc. SIGI | $5.9 billion | 11.95 | 14.8% | 11.9% | 4.0% | 0.26 | 1.7% |
| Mgic Investment Corp. MTG | $5.8 billion | 8.89 | 14.3% | 73.2% | -2.2% | n/a | 2.2% |
| Essent Group Ltd. ESNT | $5.6 billion | 8.67 | 12.2% | 59.2% | 9.6% | n/a | 2.1% |
| White Mountains Insurance Group Ltd. WTM | $5.4 billion | 5.95 | 18.1% | 30.7% | 44.9% | 0.17 | 0.0% |
| CNO Financial Group, Inc. CNO | $5.1 billion | 12.66 | 18.0% | 14.8% | 2.3% | 0.58 | 1.2% |
| Radian Group Inc. RDN | $4.7 billion | 8.81 | 12.0% | 38.3% | 65.3% | 0.13 | 2.8% |
| Mercury General Corp. MCY | $4.6 billion | 7.12 | 22.9% | 12.9% | 5.4% | 0.20 | 1.5% |
| Accelerant Holdings ARX | $4.3 billion | n/a | -180.6% | -110.8% | n/a | 0.17 | n/a |
| Corvel Corp. CRVL | $4.2 billion | 34.94 | 28.2% | n/a | 8.3% | n/a | n/a |
| Palomar Holdings, Inc. PLMR | $4.1 billion | 19.51 | 22.0% | 22.8% | 58.5% | 0.30 | n/a |
| Neptune Insurance Holdings Inc. NP | $3.9 billion | 90.02 | n/a | 41.3% | n/a | n/a | n/a |
| Hamilton Insurance Group, Ltd. HG | $3.6 billion | 7.06 | 31.2% | 28.3% | 14.8% | 0.05 | n/a |
| Assured Guaranty Ltd. AGO | $3.2 billion | 10.40 | 6.0% | 33.8% | -4.2% | 0.32 | 2.0% |
| Genworth Financial Inc. GNW | $3.2 billion | 67.00 | 0.6% | 3.3% | -0.6% | 0.17 | n/a |
| Lemonade, Inc. LMND | $3.1 billion | n/a | -30.6% | -12.6% | 69.5% | n/a | n/a |
| F&G Annuities & Life, Inc. FG | $3.1 billion | 3.10 | 23.8% | n/a | -0.4% | 0.51 | 4.3% |
| Slide Insurance Holdings, Inc. SLDE | $3.0 billion | 5.89 | 44.8% | 50.4% | n/a | 0.02 | n/a |
| SiriusPoint Ltd. SPNT | $3.0 billion | 6.40 | 22.5% | 17.6% | 18.1% | 0.30 | n/a |
| Baldwin Insurance Group, Inc. BWIN | $3.0 billion | n/a | -9.2% | -6.9% | 18.9% | 2.67 | n/a |
| NMI Holdings, Inc. NMIH | $2.9 billion | 7.66 | 14.5% | 68.1% | 6.9% | n/a | n/a |
| Skyward Specialty Insurance Group, Inc. SKWD | $2.7 billion | 14.07 | 15.0% | 13.5% | 35.3% | 0.33 | n/a |
| Porch Group, Inc. PRCH | $2.6 billion | 246.38 | 127.2% | 7.7% | 23.4% | 53.60 | n/a |
| Clover Health Investments, Corp. CLOV | $2.6 billion | 483.00 | 3.2% | 0.5% | 54.5% | 0.00 | n/a |
| Brighthouse Financial, Inc. BHF | $2.5 billion | 4.37 | 13.6% | 14.0% | -9.4% | 0.63 | n/a |
| HCI Group, Inc. HCI | $2.3 billion | 7.52 | 29.3% | 49.6% | 20.1% | 0.03 | 0.9% |
| Horace Mann Educators Corp. HMN | $2.2 billion | 12.41 | 12.5% | 12.5% | 4.2% | 0.42 | 2.7% |
| Goosehead Insurance, Inc. GSHD | $2.0 billion | 40.58 | n/a | 23.3% | 17.7% | n/a | n/a |
| Kemper Corp. KMPR | $2.0 billion | n/a | -22.6% | n/a | -4.5% | 0.43 | 3.8% |
| Trupanion, Inc. TRUP | $1.6 billion | 60.31 | 6.7% | 1.8% | 11.4% | 0.26 | n/a |
| Alignment Healthcare, Inc. ALHC | $1.5 billion | 56.38 | 10.4% | 0.9% | 35.9% | 1.17 | n/a |
| Safety Insurance Group Inc. SAFT | $1.5 billion | 21.82 | 8.2% | 7.0% | 4.6% | 0.06 | 3.5% |
| Twfg, Inc. TWFG | $1.5 billion | 47.51 | 17.4% | 17.3% | 36.2% | 0.05 | n/a |
| Stewart Information Services Corp. STC | $1.4 billion | 11.77 | 7.2% | 5.2% | 20.5% | 0.39 | 4.5% |
| Universal Insurance Holdings, Inc. UVE | $1.3 billion | 5.83 | 36.0% | 19.0% | 5.5% | 0.15 | 1.3% |
| United Fire Group Inc. UFCS | $1.2 billion | 9.10 | 14.6% | 11.5% | 11.6% | 0.16 | 1.6% |
| Ategrity Specialty Insurance Co. Holdings ASIC | $1.2 billion | 12.17 | 15.0% | 24.4% | n/a | n/a | 0.0% |
| Bowhead Specialty Holdings Inc. BOW | $1.1 billion | 19.15 | 13.3% | 11.7% | 23.8% | 0.33 | n/a |
| Heritage Insurance Holdings, Inc. HRTG | $983 million | 4.67 | 36.1% | 34.1% | 2.3% | 0.12 | n/a |
| Hippo Holdings Inc. HIPO | $929 million | 28.82 | 6.8% | 6.2% | 20.6% | n/a | n/a |
| Employers Holdings, Inc. EIG | $832 million | 25.99 | 3.5% | 4.1% | -13.0% | 0.16 | 2.8% |
| Donegal Group Inc. DGICA | $701 million | 10.02 | 10.5% | 8.9% | -3.4% | n/a | 4.0% |
| Root, Inc. ROOT | $659 million | 9.13 | 24.8% | 6.7% | 7.9% | 0.60 | n/a |
| Ethos Technologies Inc. LIFE | $558 million | n/a | -23.0% | -16.1% | n/a | n/a | n/a |
| Crawford & Co. CRD-A | $554 million | 21.94 | 14.1% | 3.9% | -3.6% | 0.81 | n/a |
| American Integrity Insurance Group, Inc. AII | $528 million | 5.99 | 23.8% | 36.2% | 29.3% | 0.00 | n/a |
| Greenlight Capital RE, Ltd. GLRE | $522 million | 9.45 | 8.4% | 8.8% | 3.7% | 0.01 | n/a |
| Investors Title Co. ITIC | $483 million | 11.98 | 14.1% | 17.7% | 8.7% | n/a | 4.1% |
| American Coastal Insurance Corp. ACIC | $475 million | 5.74 | 24.5% | 37.7% | -5.3% | 0.42 | 7.5% |
| Amerisafe Inc. AMSF | $363 million | 9.10 | 17.0% | 15.0% | 7.7% | n/a | 8.3% |
| NI Holdings, Inc. NODK | $311 million | 21.26 | 6.1% | 7.7% | -12.9% | 0.01 | n/a |
| Kingstone Companies, Inc. KINS | $296 million | 7.12 | 30.7% | 21.2% | 24.5% | 0.03 | 0.8% |
| Mbia Inc. MBI | $235 million | n/a | n/a | -155.2% | 18.0% | n/a | n/a |
| Kingsway Corp. KWY | $230 million | n/a | -79.5% | 0.7% | 23.6% | 5.13 | n/a |
| Octave Specialty Group Inc. OSG | $226 million | n/a | -23.0% | -24.3% | 26.8% | 0.22 | n/a |
| Citizens, Inc. CIA | $208 million | 25.69 | 4.0% | 3.8% | 4.1% | n/a | n/a |
| James River Group Holdings, Inc. JRVR | $180 million | 10.14 | 5.8% | 3.8% | -1.8% | n/a | 1.0% |
| Roadzen Inc. RDZN | $100 million | n/a | n/a | -21.6% | 30.5% | n/a | n/a |
| Ryan Specialty Holdings, Inc. RYAN | n/a | n/a | 23.4% | 15.6% | 9.8% | 8.23 | 1.1% |
9 companies share its SEC industry code (Hospital & Medical Service Plans); the rest are the names nearest in size in its wider industry, Insurance, one of the Fama-French 48 industries, a published grouping of SEC industry codes.
Read more
By market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.The public record on HUM
| Dividends | $3.54 a share over the four quarters to 30 September 2026, a 0.82% yield |
| Filings | 26 in twelve months: 16 current reports (8-K), about 11 regulation FD disclosure; 4 results of operations; 3 officer or director change; 2 material agreement; 2 new financial obligation |
| Planned insider sales | no Form 144 notice in twelve months |
| Options tape | put/call 1.05 by open interest at the 6 November 2026 close; the straddle prices a 5.7% move to 13 November 2026 |
| 13F holders | 932 funds reported a position for the quarter to 30 June 2026; largest Dodge & Cox |
| Insider trading | 0 sales and 1 purchase on Form 4 in twelve months |
| Congress | 0 House trades disclosed in six months |
| Short interest | 3.7 million shares short, 1.98 days to cover at 15 October 2026 |
| Documents | the 10-K, the 10-Qs, the proxy and 4 earnings press releases, each linked |
Filings
| Filing | Period | Filed | Where |
|---|---|---|---|
| 10-Q | 30 September 2026 | 6 November 2026 | EDGAR |
| 10-Q | 30 June 2026 | 29 July 2026 | EDGAR |
| 10-Q | 31 March 2026 | 29 April 2026 | EDGAR |
| 10-K | 31 December 2025 | 19 February 2026 | EDGAR |
| 10-Q | 30 September 2025 | 5 November 2025 | EDGAR |
| 10-Q | 30 June 2025 | 30 July 2025 | EDGAR |
| 10-Q | 31 March 2025 | 30 April 2025 | EDGAR |
| 10-K | 31 December 2024 | 20 February 2025 | EDGAR |
| 10-Q | 30 September 2024 | 30 October 2024 | EDGAR |
| 10-Q | 30 June 2024 | 31 July 2024 | EDGAR |
Reading about a stock somewhere else? Our free Chrome extension, GreekSoup Stock Ticker Lookup: Earnings, Insider Trades, 13F Holders, shows the latest quarter against a year ago, insider trades and 13F holders when you hover a $ticker such as $AAPL.